Gene therapy is the therapeutic delivery of nucleic acid into a patient's cells as a drug to treat disease. Research in gene therapy for cancer is currently focused in multiple areas, including genetically engineered viruses that directly kill cancer cells, gene transfer to alter the abnormal functioning of cancer cells, and immunotherapy (which includes CAR T-cell therapy), which helps the immune system better find and kill.

The global Gene Therapies for Tumor Treatment market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Gene Therapies for Tumor Treatment volume and value at global level, regional level and company level. From a global perspective, this report represents overall Gene Therapies for Tumor Treatment market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
Novartis
Kite Pharma
Amgen
Shanghai Sunway
Sibiono
...

Segment by Regions
North America
Europe
China
Japan

Segment by Type
Gene Induced Immunotherapy
Oncolytic Virotherapy
Gene Transfer

Segment by Application
Hospital
Clinic
Other